Cystografin-Dilute Side Effects
Generic name: diatrizoate
Medically reviewed by Drugs.com. Last updated on Jan 13, 2024.
Note: This document provides detailed information about Cystografin-Dilute Side Effects associated with diatrizoate. Some dosage forms listed on this page may not apply specifically to the brand name Cystografin-Dilute.
Applies to diatrizoate: intravenous solution.
Serious side effects of Cystografin-Dilute
Along with its needed effects, diatrizoate (the active ingredient contained in Cystografin-Dilute) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor or nurse immediately if any of the following side effects occur while taking diatrizoate:
Incidence not known
- blood in the urine
- convulsions
- cough
- decrease in the amount of urine
- difficulty with swallowing
- dizziness
- fast heartbeat
- hives, itching, or rash
- not able to pass urine
- pain or burning while urinating
- puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
- shortness of breath
- tightness in the chest
- unusual tiredness or weakness
For healthcare professionals
Applies to diatrizoate: injectable powder for injection, injectable solution, oral powder for reconstitution, oral and rectal solution.
General
The most frequently reported adverse reactions were vomiting, nausea, diarrhea, erythema, a sensation of pain, and a general feelings of warmth on intravascular administration.[Ref]
Cardiovascular
- Uncommon (0.1% to 1%): Thrombophlebitis, venous thrombosis
- Rare (0.01% to 0.1%): Thromboembolic events, myocardial infarction
- Very rare (less than 0.01%): Severe hypotension and collapse; circulatory failure; ventricular fibrillation
- Frequency not reported: Tachycardia, shock, hypotension, hypertension, reflex tachycardia, cyanosis[Ref]
Common (1% to 10%) Transient disturbance in heart rate, blood pressure, disturbance in cardiac rhythm or function, cardiac arrest
Gastrointestinal
- Common (1% to 10%): Nausea, vomit, diarrhea
- Frequency not reported: Diarrhea (ceases as soon as the intestine has been emptied); existing enteritis or colitis may be temporarily exacerbated; in case of obstruction, the prolonged contact with bowel mucosa can lead to erosions and to bowel necrosis; intestinal perforation; abdominal pain; oral mucosal blistering[Ref]
Hypersensitivity
- Common (1% to 10%): Anaphylactoid reactions (mild angioedema, conjunctivitis, coughing pruritus, rhinitis, sneezing, urticarial)[Ref]
Respiratory
- Common (1% to 10%): Transient disturbances in respiratory rate, dyspnea, respiratory distress, cough
- Rare (less than 0.1%): Respiratory arrest, pulmonary edema
- Frequency not reported: Bronchospasm, medication aspiration, pulmonary edema following aspiration, aspiration pneumonia, sneezing, laryngeal spasm[Ref]
Endocrine
- Uncommon (0.1% to 1%): Thyroid function tests indicative of hypothyroidism or transient thyroid suppression in adults and pediatric patients (including infants)
- Frequency not reported: Hyperthyroidism[Ref]
Dermatologic
- Rare (less than 0.1%): Toxic epidermal necrolysis, urticaria, rash, pruritus, erythema, face edema, mucocutaneous syndrome (e.g. Stevens-Johnson's or Lyell syndrome)
- Frequency not reported: Sweating, mild angioedema[Ref]
Nervous system
- Very rare (less than 0.01%): Convulsions, cerebral symptoms
- Frequency not reported: Disturbances in consciousness, dizziness, headache, tremor, somnolence, transient paresis (vision or facial muscle paresis and epileptic fits), amnesia, photophobia, temporary states of agitation or confusion[Ref]
Genitourinary
- Frequency not reported: Perforation of the urethra, genitourinary tract infections, oliguria, hematuria, anuria[Ref]
Local
- Frequency not reported: Local pain, edema[Ref]
Metabolic
- Frequency not reported: Fluid and electrolyte imbalance[Ref]
Ocular
- Frequency not reported: Lacrimation, temporary blindness[Ref]
Other
- Frequency not reported: Pyrexia, sweating, chills, blanching, weakness, gagging and feeling suffocated, gasping, edema, cramp, malaise[Ref]
Renal
- Frequency not reported: Temporary renal failure[Ref]
References
1. Cerner Multum, Inc. "UK Summary of Product Characteristics."
2. Cerner Multum, Inc. "Australian Product Information."
More about Cystografin-Dilute (diatrizoate)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Dosage information
- During pregnancy
- Drug class: ionic iodinated contrast media
- Breastfeeding
Patient resources
Other brands
Gastrografin, MD-Gastroview, Hypaque Meglumine, MD-76 R, ... +3 more
Professional resources
Other brands
Gastrografin, Hypaque, MD-Gastroview, Renografin-60
Other formulations
Related treatment guides
Further information
Cystografin-Dilute side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.